EIDX: Eidos Therapeutics, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Eidos Therapeutics, Inc.

NASDAQ:EIDX

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$122.21
Loss Chance
58.4%
0.92JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
AbbVie
NYSE:ABBV
6.05
$234.76
144.09%
Acorda Therapeutics
NASDAQ:ACOR
2.03
$0.01
99.83%
Alexion Pharmaceuticals
NASDAQ:ALXN
6.89
$182.50
52.20%
Amgen
NASDAQ:AMGN
6.24
$347.01
44.17%
Biogen
NASDAQ:BIIB
5.83
$197.19
15.05%
Jitta Factors
Growth Opportunity (3)
Recent Business Performance (22)
Financial Strength (38)
Return to Shareholders (0)
Competitive Advantage (0)
Jitta Signs
Cash Conversion CycleLess than 30 days
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 404.68% in the last quarter (yoy)
SG&A to SalesIncreasing Every Year
Key Stats
Jitta Score
Jitta Line
0.92
100.00%
2.07
348.75%
2.07
348.75%
6.89
52.20%
COMPANY DESCRIPTION
Eidos Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drugs to treat diseases caused by transthyretin (TTR) or amyloidosis (ATTR). It is developing AG10, which is in phase 3 clinical trial, is an orally-administered small molecule designed to stabilize tetrameric TTR, thereby halting at its outset the series of molecular events that give rise to ATTR. The company was founded in 2013 and is headquartered in San Francisco, California. Eidos Therapeutics, Inc. is a subsidiary of BridgeBio Pharma, Inc.
www.eidostx.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.